Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 356

1.

A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan.

Rocha-Lima CM, de Queiroz Marques Junior E, Bayraktar S, Broome P, Weissman C, Nowacki M, Leslie M, Susnerwala S.

Cancer Chemother Pharmacol. 2014 Sep;74(3):479-86. doi: 10.1007/s00280-014-2520-y. Epub 2014 Jul 17.

PMID:
25030089
[PubMed - indexed for MEDLINE]
2.

A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.

Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM.

J Infect Dis. 2014 Dec 1;210(11):1763-71. doi: 10.1093/infdis/jiu337. Epub 2014 Jun 20.

PMID:
24951828
[PubMed - indexed for MEDLINE]
3.

Parenteral administration of attenuated Salmonella Typhimurium ΔznuABC is protective against salmonellosis in piglets.

Ruggeri J, Pesciaroli M, Gaetarelli B, Scaglione FE, Pregel P, Ammendola S, Battistoni A, Bollo E, Alborali GL, Pasquali P.

Vaccine. 2014 Jul 7;32(32):4032-8. doi: 10.1016/j.vaccine.2014.05.066. Epub 2014 Jun 4.

PMID:
24907486
[PubMed - indexed for MEDLINE]
4.

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Potter DM, Connelly AK, Dibridge SA, Whiteside TL, Okada H.

J Clin Oncol. 2014 Jul 1;32(19):2050-8. doi: 10.1200/JCO.2013.54.0526. Epub 2014 Jun 2.

PMID:
24888813
[PubMed - indexed for MEDLINE]
5.

Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial.

McAllister L, Anderson J, Werth K, Cho I, Copeland K, Le Cam Bouveret N, Plant D, Mendelman PM, Cobb DK.

Lancet. 2014 Aug 23;384(9944):674-81. doi: 10.1016/S0140-6736(14)60524-9. Epub 2014 May 31.

PMID:
24881803
[PubMed - indexed for MEDLINE]
6.

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.

Pondo T, Rose CE Jr, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM.

Vaccine. 2014 Jun 12;32(28):3548-54. doi: 10.1016/j.vaccine.2014.04.025. Epub 2014 Apr 24.

PMID:
24768633
[PubMed - indexed for MEDLINE]
7.

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.

Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, Li J, Wang S, Hu Y, Gu S, Zhang J, Yao G, Gu J, Wang X, Zhou Y, Chen C, Zhang M, Cao M, Wang J, Wang H, Wang N.

N Engl J Med. 2014 Feb 27;370(9):818-28. doi: 10.1056/NEJMoa1304923.

PMID:
24571754
[PubMed - indexed for MEDLINE]
Free Article
8.

Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.

Herzog C.

Expert Rev Vaccines. 2014 Mar;13(3):399-415. doi: 10.1586/14760584.2014.883285. Epub 2014 Feb 10. Review.

PMID:
24512188
[PubMed - indexed for MEDLINE]
9.

Intramuscular DNA vaccination protocols mediated by electric fields.

Chiarella P, Signori E.

Methods Mol Biol. 2014;1121:315-24. doi: 10.1007/978-1-4614-9632-8_28.

PMID:
24510835
[PubMed - indexed for MEDLINE]
10.

Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.

Wang BZ, Gill HS, He C, Ou C, Wang L, Wang YC, Feng H, Zhang H, Prausnitz MR, Compans RW.

J Control Release. 2014 Mar 28;178:1-7. doi: 10.1016/j.jconrel.2014.01.002. Epub 2014 Jan 11.

PMID:
24417966
[PubMed - indexed for MEDLINE]
11.

Generation of a safety enhanced Salmonella Gallinarum ghost using antibiotic resistance free plasmid and its potential as an effective inactivated vaccine candidate against fowl typhoid.

Jawale CV, Chaudhari AA, Lee JH.

Vaccine. 2014 Feb 19;32(9):1093-9. doi: 10.1016/j.vaccine.2013.12.053. Epub 2014 Jan 7.

PMID:
24406393
[PubMed - indexed for MEDLINE]
12.

Salmonid alphavirus-based replicon vaccine against infectious salmon anemia (ISA): impact of immunization route and interactions of the replicon vector.

Wolf A, Hodneland K, Frost P, Hoeijmakers M, Rimstad E.

Fish Shellfish Immunol. 2014 Feb;36(2):383-92. doi: 10.1016/j.fsi.2013.12.018. Epub 2013 Dec 27.

PMID:
24374059
[PubMed - indexed for MEDLINE]
13.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
[PubMed - indexed for MEDLINE]
14.

Safety of Porcine Reproductive and Respiratory Syndrome Modified Live Virus (MLV) vaccine strains in a young pig infection model.

Martínez-Lobo FJ, de Lome LC, Díez-Fuertes F, Segalés J, García-Artiga C, Simarro I, Castro JM, Prieto C.

Vet Res. 2013 Dec 5;44:115. doi: 10.1186/1297-9716-44-115.

PMID:
24308693
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia.

McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N.

Pediatr Blood Cancer. 2014 May;61(5):815-20. doi: 10.1002/pbc.24863. Epub 2013 Nov 19.

PMID:
24249544
[PubMed - indexed for MEDLINE]
16.

Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.

Tsang P, Gorse GJ, Strout CB, Sperling M, Greenberg DP, Ozol-Godfrey A, DiazGranados C, Landolfi V.

Vaccine. 2014 May 1;32(21):2507-17. doi: 10.1016/j.vaccine.2013.09.074. Epub 2013 Oct 11.

PMID:
24120672
[PubMed - indexed for MEDLINE]
Free Article
17.

A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.

Westritschnig K, Hochreiter R, Wallner G, Firbas C, Schwameis M, Jilma B.

Hum Vaccin Immunother. 2014 Jan;10(1):170-83. doi: 10.4161/hv.26565. Epub 2013 Sep 24.

PMID:
24064511
[PubMed - indexed for MEDLINE]
18.

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.

Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, Bakker WA.

Vaccine. 2013 Nov 12;31(47):5531-6. doi: 10.1016/j.vaccine.2013.09.021. Epub 2013 Sep 21.

PMID:
24063976
[PubMed - indexed for MEDLINE]
19.

Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.

Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH.

Vaccine. 2013 Dec 5;31(50):6034-40. doi: 10.1016/j.vaccine.2013.09.012. Epub 2013 Sep 20.

PMID:
24055306
[PubMed - indexed for MEDLINE]
20.

Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.

Diehl MC, Lee JC, Daniels SE, Tebas P, Khan AS, Giffear M, Sardesai NY, Bagarazzi ML.

Hum Vaccin Immunother. 2013 Oct;9(10):2246-52. doi: 10.4161/hv.24702. Epub 2013 Jun 4.

PMID:
24051434
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk